De-Identified Data Use Sample Clauses
The De-Identified Data Use clause defines how data that has been stripped of personal identifiers can be used by the parties involved. Typically, this clause permits the collection, analysis, and sharing of data sets from which names, contact information, and other identifying details have been removed, ensuring individuals cannot be readily identified. Its core function is to enable the use of valuable data for research, analytics, or product improvement while protecting individual privacy and complying with data protection regulations.
POPULAR SAMPLE Copied 1 times
De-Identified Data Use. INAP and its licensors may use certain content and transaction information to create information that is de-identified, such that it cannot be identified to the Customer, and which is sometime referred to as “big data” (hereinafter “Content”). Content may be used and disclosed consistent with applicable law. Customer grants to INAP and its licensors a non-exclusive right and license to use Content including the right of aggregation with data received from other customers, suppliers and users of INAP services for the general provision of data aggregation and comparison services, statistical analysis, the creation and maintenance of comparative databases, product support and development, system analytics, and benchmarking analysis, so long as INAP does not identify Customer or any individual person associated with Customer and the data remains in an aggregated form. To the extent that the Content has been de-identified, and notwithstanding anything set forth herein to the contrary in this Agreement, INAP may retain such Content, provided that such Content shall be used or disclosed solely for such purposes provided in this Section.
De-Identified Data Use. De-identified data may be used regardless of opt-in/out for population reporting, business intelligence, mapping, program and service evaluation, analytic and statistical purposes, and other purposes that do not require use of or would indirectly reveal patient/beneficiary identifiers.
De-Identified Data Use. QIAGEN may utilize data capture, syndication and analysis tools, and other similar tools, to create, extract, compile, keep, aggregate or synthesize data, usage patterns or information which has been de-identified consistent with applicable data privacy laws and associated data protection standards resulting from Customers’ use of the Licensed Materials, which shall include but not be limited to, Customer Biological Data and Results (“De-identified Data”). QIAGEN may
(i) use and analyze the De-identified Data internally to test, develop and improve QIAGEN’s products and services,
(ii) use usage patterns as part of QIAGEN’s products and services, and
(iii) use De-identified Data obtained through QCI for commercial use and other applications, including without limitation, health, research or patient care. QIAGEN will ensure that no personally identifiable information provided by Customer is disclosed through the QIAGEN products and services to any third party without Customer’s consent.